Clinical Trial Update: Triple Site Ventricular Stimulation for Cardiac Resynchronization Therapy (CRT) Candidates [Phase 3]

View source ↗

Summary

Phase 3 trial of triple-site ventricular stimulation for cardiac resynchronization therapy in heart failure patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Heart Failure | Phase 3 | Status: COMPLETED